MMPP
MMPP is a novel VEGFR2 inhibitor with anti-inflammatory and potential anticancer activity, inhibits STAT3, inhibits angiogenesis via VEGFR2/AKT/ERK/NF-kappaB pathway, and can be used to alleviate myocardial injury.
Product Specifications
CAS Number
1895957-18-2
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
270.32
Molecular Formula
C17H18O3
Notes
Research use only, not for human use.
Receptor
STAT | VEGFR
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6442838-01 0.1 mL
UTS2R (Urotensin 2 Receptor, UTR, UTR2, GPR14, UR-2-R) (MaxLight 550)
Sign In for Pricing
View Details MBS6442838-02 5x 0.1 mL
UTS2R (Urotensin 2 Receptor, UTR, UTR2, GPR14, UR-2-R) (MaxLight 550)
Sign In for Pricing
View Details